๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A community perspective on multiple infliximab infusions in inflammatory bowel disease

โœ Scribed by Marie Harty; Mark Kasowitz

Book ID
119393464
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
26 KB
Volume
97
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Are accelerated infliximab infusions saf
Are accelerated infliximab infusions safe in patients with inflammatory bowel disease?
โœ Shivaram Bhat; Divyesh Sharma; Pauline Doherty; Tony C.K. Tham; Grant R. Caddy ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB

Background: Infliximab is a monoclonal antibody used in the treatment of inflammatory bowel disease (IBD). The manufacturerrecommended administration is over 2 hours followed by 2 hours of patient observation. The data relating to adverse outcomes in patients receiving accelerated infusions for IBD

Infliximab in pediatric inflammatory bow
Infliximab in pediatric inflammatory bowel disease
โœ A.J. Katz; J. Biller; A. Flores; T. Schnorr; M. Pacetti; G. Smith ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 28 KB